{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:23:28Z","timestamp":1789086208089,"version":"build-2803163510"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Monoclonal antibodies (mAbs) against Ebola virus (EBOV) glycoprotein (GP\n                    <jats:sub>1,2<\/jats:sub>\n                    ) are the standard of care for Ebola virus disease (EVD). Anti-GP\n                    <jats:sub>1,2<\/jats:sub>\n                    mAbs targeting the stalk and membrane proximal external region (MPER) potently neutralize EBOV in vitro and are protective in a mouse model of EVD. However, their neutralization mechanism is poorly understood because they target a GP\n                    <jats:sub>1,2<\/jats:sub>\n                    epitope that has evaded structural characterization. Using X-ray crystallography and cryo-electron tomography of mAb 3A6 complexed with its stalk\u2013MPER epitope, we reveal a previously undescribed mechanism in which 3A6 binds to a conformation of GP\n                    <jats:sub>1,2<\/jats:sub>\n                    that is lifted from the virion membrane. We further show that in both domestic guinea pig and rhesus monkey EVD models, 3A6 provides therapeutic benefit at high-viremia advanced disease stages and at the lowest dose yet demonstrated for any anti-EBOV mAb-based monotherapy. The findings reported here can guide design of next-generation highly potent anti-EBOV therapeutics and vaccines.\n                  <\/jats:p>","DOI":"10.1038\/s41467-025-56452-2","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T08:48:56Z","timestamp":1738572536000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Anti-Ebola virus mAb 3A6 protects highly viremic animals from fatal outcome via binding GP(1,2) in a position elevated from the virion membrane"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3406-1210","authenticated-orcid":false,"given":"Kathryn M.","family":"Hastie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2063-1013","authenticated-orcid":false,"given":"Zhe Li","family":"Salie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zunlong","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1648-1625","authenticated-orcid":false,"given":"Peter J.","family":"Halfmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa Evans","family":"DeWald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3795-3772","authenticated-orcid":false,"given":"Sara","family":"McArdle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0185-2734","authenticated-orcid":false,"given":"Ariadna","family":"Griny\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5062-7261","authenticated-orcid":false,"given":"Sharon L.","family":"Schendel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chitra","family":"Hariharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8325-5257","authenticated-orcid":false,"given":"Michael J.","family":"Norris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6778-5004","authenticated-orcid":false,"given":"Xiaoying","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chakravarthy","family":"Chennareddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4632-9122","authenticated-orcid":false,"given":"Xiaoli","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3079-6500","authenticated-orcid":false,"given":"Megan","family":"Heinrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0824-2667","authenticated-orcid":false,"given":"Michael R.","family":"Holbrook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8245-3083","authenticated-orcid":false,"given":"Benjamin","family":"Doranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2485-4011","authenticated-orcid":false,"given":"Ian","family":"Crozier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5061-8296","authenticated-orcid":false,"given":"Yoshihiro","family":"Kawaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis M.","family":"Branco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7800-6045","authenticated-orcid":false,"given":"Jens H.","family":"Kuhn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3990-6910","authenticated-orcid":false,"given":"John A. G.","family":"Briggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Worwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl W.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9591-2621","authenticated-orcid":false,"given":"Rafi","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1206-7451","authenticated-orcid":false,"given":"Erica Ollmann","family":"Saphire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,3]]},"reference":[{"key":"56452_CR1","unstructured":"Kuhn, J. H., Amarasinghe, G. K. & Perry, D. L. Filoviridae. In Fields virology, Vol. 1 (eds. Howley, P. M., Knipe, D. M. & Whelan, S. P. J.) 449-503 (Wolters Kluwer\/Lippincott Williams & Wilkins, Philadelphia, Pennsylvania, USA, 2020)."},{"key":"56452_CR2","doi-asserted-by":"publisher","first-page":"374","DOI":"10.3390\/pathogens11030374","volume":"11","author":"X Yu","year":"2022","unstructured":"Yu, X. & Saphire, E. O. Development and structural analysis of antibody therapeutics for filoviruses. Pathogens 11, 374 (2022).","journal-title":"Pathogens"},{"key":"56452_CR3","doi-asserted-by":"publisher","first-page":"6442","DOI":"10.1128\/JVI.72.8.6442-6447.1998","volume":"72","author":"A Sanchez","year":"1998","unstructured":"Sanchez, A. et al. Biochemical analysis of the secreted and virion glycoproteins of Ebola virus. J. Virol. 72, 6442\u20136447 (1998).","journal-title":"J. Virol."},{"key":"56452_CR4","doi-asserted-by":"publisher","first-page":"5762","DOI":"10.1073\/pnas.95.10.5762","volume":"95","author":"VE Volchkov","year":"1998","unstructured":"Volchkov, V. E., Feldmann, H., Volchkova, V. A. & Klenk, H.-D. Processing of the Ebola virus glycoprotein by the proprotein convertase furin. Proc. Natl Acad. Sci. USA 95, 5762\u20135767 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"56452_CR5","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.cell.2015.12.044","volume":"164","author":"H Wang","year":"2016","unstructured":"Wang, H. et al. Ebola viral glycoprotein bound to its endosomal receptor Niemann-Pick C1. Cell 164, 258\u2013268 (2016).","journal-title":"Cell"},{"key":"56452_CR6","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1126\/science.1110656","volume":"308","author":"K Chandran","year":"2005","unstructured":"Chandran, K., Sullivan, N. J., Felbor, U., Whelan, S. P. & Cunningham, J. M. Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science 308, 1643\u20131645 (2005).","journal-title":"Science"},{"key":"56452_CR7","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nature07082","volume":"454","author":"JE Lee","year":"2008","unstructured":"Lee, J. E. et al. Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature 454, 177\u2013182 (2008).","journal-title":"Nature"},{"key":"56452_CR8","doi-asserted-by":"publisher","first-page":"E7987","DOI":"10.1073\/pnas.1708052114","volume":"114","author":"J Lee","year":"2017","unstructured":"Lee, J. et al. Structure of the Ebola virus envelope protein MPER\/TM domain and its interaction with the fusion loop explains their fusion activity. Proc. Natl Acad. Sci. USA 114, E7987\u2013E7996 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"56452_CR9","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1126\/science.aad5788","volume":"351","author":"ZA Bornholdt","year":"2016","unstructured":"Bornholdt, Z. A. et al. Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak. Science 351, 1078\u20131083 (2016).","journal-title":"Science"},{"key":"56452_CR10","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1126\/science.aad5224","volume":"351","author":"D Corti","year":"2016","unstructured":"Corti, D. et al. Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody. Science 351, 1339\u20131342 (2016).","journal-title":"Science"},{"key":"56452_CR11","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1016\/j.cell.2019.04.036","volume":"177","author":"CW Davis","year":"2019","unstructured":"Davis, C. W. et al. Longitudinal analysis of the human B cell response to Ebola virus infection. Cell 177, 1566\u20131582.e1517 (2019).","journal-title":"Cell"},{"key":"56452_CR12","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1038\/s41591-019-0602-4","volume":"25","author":"SA Ehrhardt","year":"2019","unstructured":"Ehrhardt, S. A. et al. Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOV. Nat. Med. 25, 1589\u20131600 (2019).","journal-title":"Nat. Med"},{"key":"56452_CR13","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.cell.2015.12.022","volume":"164","author":"AI Flyak","year":"2016","unstructured":"Flyak, A. I. et al. Cross-reactive and potent neutralizing antibody responses in human survivors of natural ebolavirus infection. Cell 164, 392\u2013405 (2016).","journal-title":"Cell"},{"key":"56452_CR14","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.cell.2018.07.033","volume":"174","author":"EO Saphire","year":"2018","unstructured":"Saphire, E. O. et al. Systematic analysis of monoclonal antibodies against Ebola virus GP defines features that contribute to protection. Cell 174, 938\u2013952.e913 (2018).","journal-title":"Cell"},{"key":"56452_CR15","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.cell.2022.02.023","volume":"185","author":"JC Milligan","year":"2022","unstructured":"Milligan, J. C. et al. Asymmetric and non-stoichiometric glycoprotein recognition by two distinct antibodies results in broad protection against ebolaviruses. Cell 185, 995\u20131007.e1018 (2022).","journal-title":"Cell"},{"key":"56452_CR16","doi-asserted-by":"publisher","first-page":"e1010518","DOI":"10.1371\/journal.ppat.1010518","volume":"18","author":"CT Schoeder","year":"2022","unstructured":"Schoeder, C. T. et al. Epitope-focused immunogen design based on the ebolavirus glycoprotein HR2-MPER region. PLoS Pathog. 18, e1010518 (2022).","journal-title":"PLoS Pathog."},{"key":"56452_CR17","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.chom.2023.01.002","volume":"31","author":"V Rayaprolu","year":"2023","unstructured":"Rayaprolu, V. et al. Structure of the Inmazeb cocktail and resistance to Ebola virus escape. Cell Host Microbe 31, 260\u2013272.e267 (2023).","journal-title":"Cell Host Microbe"},{"key":"56452_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09732-7","volume":"10","author":"LB King","year":"2019","unstructured":"King, L. B. et al. Cross-reactive neutralizing human survivor monoclonal antibody BDBV223 targets the ebolavirus stalk. Nat. Commun. 10, 1788 (2019).","journal-title":"Nat. Commun."},{"key":"56452_CR19","doi-asserted-by":"publisher","first-page":"17182","DOI":"10.1073\/pnas.1414164111","volume":"111","author":"CD Murin","year":"2014","unstructured":"Murin, C. D. et al. Structures of protective antibodies reveal sites of vulnerability on Ebola virus. Proc. Natl Acad. Sci. USA 111, 17182\u201317187 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"56452_CR20","doi-asserted-by":"publisher","first-page":"10982","DOI":"10.1128\/JVI.01490-15","volume":"89","author":"E Davidson","year":"2015","unstructured":"Davidson, E. et al. Mechanism of binding to Ebola virus glycoprotein by the ZMapp, ZMAb, and MB-003 cocktail antibodies. J. Virol. 89, 10982\u201310992 (2015).","journal-title":"J. Virol."},{"key":"56452_CR21","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1073\/pnas.0708057105","volume":"105","author":"P Halfmann","year":"2008","unstructured":"Halfmann, P. et al. Generation of biologically contained Ebola viruses. Proc. Natl Acad. Sci. USA 105, 1129\u20131133 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"56452_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22867-w","volume":"12","author":"L He","year":"2021","unstructured":"He, L. et al. Single-component multilayered self-assembling nanoparticles presenting rationally designed glycoprotein trimers as Ebola virus vaccines. Nat. Commun. 12, 2633 (2021).","journal-title":"Nat. Commun."},{"key":"56452_CR23","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nature18615","volume":"535","author":"Y Zhao","year":"2016","unstructured":"Zhao, Y. et al. Toremifene interacts with and destabilizes the Ebola virus glycoprotein. Nature 535, 169\u2013172 (2016).","journal-title":"Nature"},{"key":"56452_CR24","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583\u2013589 (2021).","journal-title":"Nature"},{"key":"56452_CR25","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41592-022-01488-1","volume":"19","author":"M Mirdita","year":"2022","unstructured":"Mirdita, M. et al. ColabFold: making protein folding accessible to all. Nat. Methods 19, 679\u2013682 (2022).","journal-title":"Nat. Methods"},{"key":"56452_CR26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.coi.2021.03.008","volume":"71","author":"O Tomori","year":"2021","unstructured":"Tomori, O. & Kolawole, M. O. Ebola virus disease: current vaccine solutions. Curr. Opin. Immunol. 71, 27\u201333 (2021).","journal-title":"Curr. Opin. Immunol."},{"key":"56452_CR27","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/s41564-018-0157-z","volume":"3","author":"AI Flyak","year":"2018","unstructured":"Flyak, A. I. et al. Broadly neutralizing antibodies from human survivors target a conserved site in the Ebola virus glycoprotein HR2-MPER region. Nat. Microbiol 3, 670\u2013677 (2018).","journal-title":"Nat. Microbiol"},{"key":"56452_CR28","doi-asserted-by":"publisher","first-page":"S612","DOI":"10.1093\/infdis\/jiy285","volume":"218","author":"KE Pascal","year":"2018","unstructured":"Pascal, K. E. et al. Development of clinical-stage human monoclonal antibodies that treat advanced Ebola virus disease in nonhuman primates. J. Infect. Dis. 218, S612\u2013S626 (2018).","journal-title":"J. Infect. Dis."},{"key":"56452_CR29","doi-asserted-by":"publisher","first-page":"10112","DOI":"10.1073\/pnas.1810927115","volume":"115","author":"DJ Benton","year":"2018","unstructured":"Benton, D. J. et al. Influenza hemagglutinin membrane anchor. Proc. Natl Acad. Sci. USA 115, 10112\u201310117 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"56452_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107583","volume":"31","author":"K Rantalainen","year":"2020","unstructured":"Rantalainen, K. et al. HIV-1 envelope and MPER antibody structures in lipid assemblies. Cell Rep. 31, 107583 (2020).","journal-title":"Cell Rep."},{"key":"56452_CR31","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/nprot.2009.3","volume":"4","author":"K Smith","year":"2009","unstructured":"Smith, K. et al. Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen. Nat. Protoc. 4, 372\u2013384 (2009).","journal-title":"Nat. Protoc."},{"key":"56452_CR32","doi-asserted-by":"publisher","first-page":"393","DOI":"10.4269\/ajtmh.1994.51.393","volume":"51","author":"T Avsic-Zupanc","year":"1994","unstructured":"Avsic-Zupanc, T. et al. Isolation of a strain of a Hantaan virus from a fatal case of hemorrhagic fever with renal syndrome in Slovenia. Am. J. Trop. Med Hyg. 51, 393\u2013400 (1994).","journal-title":"Am. J. Trop. Med Hyg."},{"key":"56452_CR33","doi-asserted-by":"publisher","first-page":"954","DOI":"10.4269\/ajtmh.2010.09-0636","volume":"82","author":"AR Trombley","year":"2010","unstructured":"Trombley, A. R. et al. Comprehensive panel of real-time TaqMan polymerase chain reaction assays for detection and absolute quantification of filoviruses, arenaviruses, and New World hantaviruses. Am. J. Trop. Med Hyg. 82, 954\u2013960 (2010).","journal-title":"Am. J. Trop. Med Hyg."},{"key":"56452_CR34","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1107\/S0907444909047337","volume":"66","author":"W Kabsch","year":"2010","unstructured":"Kabsch, W. XDS. Acta Crystallogr D. Biol. Crystallogr 66, 125\u2013132 (2010).","journal-title":"Acta Crystallogr D. Biol. Crystallogr"},{"key":"56452_CR35","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1107\/S0907444911007773","volume":"67","author":"C Vonrhein","year":"2011","unstructured":"Vonrhein, C. et al. Data processing and analysis with the autoPROC toolbox. Acta Crystallogr D. Biol. Crystallogr 67, 293\u2013302 (2011).","journal-title":"Acta Crystallogr D. Biol. Crystallogr"},{"key":"56452_CR36","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1107\/S090744491003982X","volume":"67","author":"PR Evans","year":"2011","unstructured":"Evans, P. R. An introduction to data reduction: space-group determination, scaling and intensity statistics. Acta Crystallogr D. Biol. Crystallogr 67, 282\u2013292 (2011).","journal-title":"Acta Crystallogr D. Biol. Crystallogr"},{"key":"56452_CR37","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1107\/S0907444913000061","volume":"69","author":"PR Evans","year":"2013","unstructured":"Evans, P. R. & Murshudov, G. N. How good are my data and what is the resolution? Acta Crystallogr D. Biol. Crystallogr 69, 1204\u20131214 (2013).","journal-title":"Acta Crystallogr D. Biol. Crystallogr"},{"key":"56452_CR38","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1107\/S0021889807021206","volume":"40","author":"AJ McCoy","year":"2007","unstructured":"McCoy, A. J. et al. Phaser crystallographic software. J. Appl Crystallogr 40, 658\u2013674 (2007).","journal-title":"J. Appl Crystallogr"},{"key":"56452_CR39","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1107\/S0907444910045749","volume":"67","author":"MD Winn","year":"2011","unstructured":"Winn, M. D. et al. Overview of the CCP4 suite and current developments. Acta Crystallogr D. Biol. Crystallogr 67, 235\u2013242 (2011).","journal-title":"Acta Crystallogr D. Biol. Crystallogr"},{"key":"56452_CR40","doi-asserted-by":"publisher","first-page":"W296","DOI":"10.1093\/nar\/gky427","volume":"46","author":"A Waterhouse","year":"2018","unstructured":"Waterhouse, A. et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res 46, W296\u2013w303 (2018).","journal-title":"Nucleic Acids Res"},{"key":"56452_CR41","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr D. Biol. Crystallogr 60, 2126\u20132132 (2004).","journal-title":"Acta Crystallogr D. Biol. Crystallogr"},{"key":"56452_CR42","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1107\/S2059798319011471","volume":"75","author":"D Liebschner","year":"2019","unstructured":"Liebschner, D. et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Crystallogr D. Struct. Biol. 75, 861\u2013877 (2019).","journal-title":"Acta Crystallogr D. Struct. Biol."},{"key":"56452_CR43","doi-asserted-by":"crossref","unstructured":"Folta-Stogniew, E. Oligomeric states of proteins determined by size-exclusion chromatography coupled with light scattering, absorbance, and refractive index detectors. in Methods in Molecular Biology, Vol. 328: New and Emerging Proteomic Techniques, Vol. 328 (eds. Nedelkov, D. & Nelson, R. W.) 97-112 (Humana Press, Totowa, NJ, USA, 2006).","DOI":"10.1385\/1-59745-026-X:97"},{"key":"56452_CR44","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1006\/abio.1996.0345","volume":"240","author":"J Wen","year":"1996","unstructured":"Wen, J., Arakawa, T. & Philo, J. S. Size-exclusion chromatography with on-line light-scattering, absorbance, and refractive index detectors for studying proteins and their interactions. Anal. Biochem 240, 155\u2013166 (1996).","journal-title":"Anal. Biochem"},{"key":"56452_CR45","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1016\/j.celrep.2018.08.009","volume":"24","author":"CD Murin","year":"2018","unstructured":"Murin, C. D. et al. Structural basis of pan-ebolavirus neutralization by an antibody targeting the glycoprotein fusion loop. Cell Rep. 24, 2723\u20132732.e2724 (2018).","journal-title":"Cell Rep."},{"key":"56452_CR46","doi-asserted-by":"publisher","first-page":"e01674","DOI":"10.1128\/mBio.01674-18","volume":"9","author":"BR West","year":"2018","unstructured":"West, B. R. et al. Structural basis of pan-ebolavirus neutralization by a human antibody against a conserved, yet cryptic epitope. mBio 9, e01674\u201301618 (2018).","journal-title":"mBio"},{"key":"56452_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead, P. et al. QuPath: open source software for digital pathology image analysis. Sci. Rep. 7, 16878 (2017).","journal-title":"Sci. Rep."},{"key":"56452_CR48","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"56452_CR49","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.59225","volume":"9","author":"W Wan","year":"2020","unstructured":"Wan, W. et al. Ebola and Marburg virus matrix layers are locally ordered assemblies of VP40 dimers. Elife 9, e59225 (2020).","journal-title":"Elife"},{"key":"56452_CR50","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/s41586-020-2665-2","volume":"588","author":"Z Ke","year":"2020","unstructured":"Ke, Z. et al. Structures and distributions of SARS-CoV-2 spike proteins on intact virions. Nature 588, 498\u2013502 (2020).","journal-title":"Nature"},{"key":"56452_CR51","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1006\/jsbi.1996.0013","volume":"116","author":"JR Kremer","year":"1996","unstructured":"Kremer, J. R., Mastronarde, D. N. & McIntosh, J. R. Computer visualization of three-dimensional image data using IMOD. J. Struct. Biol. 116, 71\u201376 (1996).","journal-title":"J. Struct. Biol."},{"key":"56452_CR52","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.jsb.2004.10.006","volume":"149","author":"S Nickell","year":"2005","unstructured":"Nickell, S. et al. TOM software toolbox: acquisition and analysis for electron tomography. J. Struct. Biol. 149, 227\u2013234 (2005).","journal-title":"J. Struct. Biol."},{"key":"56452_CR53","doi-asserted-by":"publisher","first-page":"4729","DOI":"10.1073\/pnas.0409178102","volume":"102","author":"F F\u00f6rster","year":"2005","unstructured":"F\u00f6rster, F., Medalia, O., Zauberman, N., Baumeister, W. & Fass, D. Retrovirus envelope protein complex structure in situ studied by cryo-electron tomography. Proc. Natl Acad. Sci. USA 102, 4729\u20134734 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"56452_CR54","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF Chimera\u2014a visualization system for exploratory research and analysis. J. Comput Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Comput Chem."},{"key":"56452_CR55","doi-asserted-by":"publisher","first-page":"E11751","DOI":"10.1073\/pnas.1811580115","volume":"115","author":"K Qu","year":"2018","unstructured":"Qu, K. et al. Structure and architecture of immature and mature murine leukemia virus capsids. Proc. Natl Acad. Sci. USA 115, E11751\u2013E11760 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"56452_CR56","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1016\/j.str.2015.06.026","volume":"23","author":"TAM Bharat","year":"2015","unstructured":"Bharat, T. A. M., Russo, C. J., L\u00f6we, J., Passmore, L. A. & Scheres, S. H. W. Advances in single-particle electron cryomicroscopy structure determination applied to sub-tomogram averaging. Structure 23, 1743\u20131753 (2015).","journal-title":"Structure"},{"key":"56452_CR57","doi-asserted-by":"publisher","first-page":"753","DOI":"10.3390\/v12070753","volume":"12","author":"RS Bennett","year":"2020","unstructured":"Bennett, R. S. et al. Kikwit Ebola virus disease progression in the rhesus monkey animal model. Viruses 12, 753 (2020).","journal-title":"Viruses"},{"key":"56452_CR58","doi-asserted-by":"publisher","first-page":"3511","DOI":"10.3390\/v4123511","volume":"4","author":"AC Shurtleff","year":"2012","unstructured":"Shurtleff, A. C. et al. Standardization of the filovirus plaque assay for use in preclinical studies. Viruses 4, 3511\u20133530 (2012).","journal-title":"Viruses"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56452-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56452-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56452-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T08:51:06Z","timestamp":1738572666000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56452-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,3]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["56452"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-56452-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3722563\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,3]]},"assertion":[{"value":"19 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.G., E.D., and B.J.D. are employees of Integral Molecular, and B.J.D. is a shareholder in that company. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Animal exposure and treatment experiments using infectious EBOV were performed in registered an ethics accredited biosafety level 4 (BSL-4) laboratories with appropriate approvals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"1293"}}